• CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip

  2026-05-15

  CAY10499 stands out as a selective, high-potency inhibitor of human hormone sensitive lipase and monoglyceride lipase for advanced lipid metabolism studies. Its robust inhibition profile, compatibility with diverse assay platforms, and proven value in immunometabolic and disease research make it indispensable for precision workflows.

• Reliable PTEN Restoration: EZ Cap™ Human PTEN mRNA in Cancer

  2026-05-14

  Discover how EZ Cap™ Human PTEN mRNA (SKU R1025) addresses core laboratory challenges in cancer research and gene therapy workflows by delivering robust, reproducible, and immune-evasive PTEN expression. This scenario-driven guide reveals best practices and protocol insights for high-fidelity tumor suppressor gene mRNA studies.

• Novel AR Antagonists Target Dimer Interface to Overcome Resi

  2026-05-14

  This study reports the discovery of benzo[b]oxepine-4-carboxamide derivatives as androgen receptor (AR) antagonists that act at the AR dimer interface pocket, rather than the conventional ligand-binding site. The dual-action compound Y5 outperforms standard therapies by both disrupting AR dimerization and inducing AR degradation, providing a promising approach against drug-resistant prostate cancer.

• Artesunate (SKU B3662): Reliable In Vitro Insights for Oncol

  2026-05-13

  This article provides scenario-driven guidance for biomedical researchers evaluating Artesunate (SKU B3662) as an artemisinin derivative in cell viability and cytotoxicity assays. Integrating evidence-backed protocol advice and practical troubleshooting, it demonstrates how high-purity Artesunate from APExBIO delivers reproducibility and confidence in small cell lung and esophageal squamous cell carcinoma workflows.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Tools for Ubiquitin

  2026-05-13

  Explore the unique applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2) as a reversible proteasome inhibitor in advanced apoptosis research and cell cycle studies. This in-depth review reveals how nuanced pathway regulation insights shape assay design and experimental interpretation.

• Hyaluronated Lipid Nanoparticles Enable Transdermal PTEN mRN

  2026-05-12

  This study introduces a hyaluronate-conjugated lipid nanoparticle (HA-LNP) platform for efficient, non-invasive transdermal delivery of PTEN tumor suppressor mRNA in melanoma models. By replacing PEG-lipids with a biocompatible HA-DMG conjugate, the approach achieves targeted tumor cell uptake, immune activation, and significant tumor growth inhibition.

• Torin2: Precision mTOR Inhibition for Advanced Cancer Models

  2026-05-12

  Torin2 stands out as a next-generation mTOR inhibitor, enabling researchers to dissect PI3K/Akt/mTOR signaling with unprecedented selectivity and potency. This guide translates recent breakthroughs into actionable workflows, protocol refinements, and troubleshooting strategies for cancer research and apoptosis assays.

• α-Amanitin in Transcriptional Regulation: Protocols & Insigh

  2026-05-11

  α-Amanitin’s precision as an RNA polymerase II inhibitor empowers researchers to dissect transcriptional regulation and gene expression pathways with unrivaled specificity. This guide delivers actionable protocols, troubleshooting strategies, and integrates cutting-edge findings—maximizing reproducibility in developmental and cellular models.

• Tin Mesoporphyrin IX (chloride): Reliable HO Inhibition for

  2026-05-11

  This article explores how Tin Mesoporphyrin IX (chloride) (SKU C5606) addresses core reproducibility and sensitivity challenges in cell-based heme oxygenase assays. Using scenario-driven analysis, we highlight validated protocols, discuss data interpretation pitfalls, and offer practical guidance on selecting Tin Mesoporphyrin IX (chloride) for metabolic and antiviral research workflows.

• SB 431542 in Primary EVT–Immune Assays: Precision Tools for

  2026-05-10

  Explore how SB 431542, a potent ALK5 inhibitor, uniquely empowers research on human extravillous trophoblast (EVT)–immune cell interactions. This article delivers an in-depth protocol and mechanistic review, bridging TGF-β signaling control with primary placental immunology.

• Applied Workflows with Recombinant Mouse Macrophage Colony S

  2026-05-09

  Unlock high-efficiency macrophage assays and advanced fibrosis modeling using Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag. This guide distills recent mechanistic breakthroughs and protocol optimization strategies, ensuring data reproducibility and translational relevance in immunology and fibrotic disease research.

• TUNEL Apoptosis Detection Kit (DAB): Mechanistic Insights an

  2026-05-08

  Discover how the TUNEL Apoptosis Detection Kit enables high-precision DNA fragmentation detection in apoptosis research. This article explores the kit’s mechanistic basis, protocol parameters, and its transformative impact on experimental design—contrasting prior scenario-driven content with a deep dive into assay optimization.

• (S)-(+)-Ibuprofen: COX Inhibition Workflows for Inflammation

  2026-05-08

  (S)-(+)-Ibuprofen from APExBIO sets a new standard for selective COX inhibition in inflammation pathway research, offering robust reproducibility and high purity for both in vitro and in vivo assays. This article delivers actionable protocols, troubleshooting guidance, and comparative insights that empower researchers to optimize pain mechanism and nonsteroidal anti-inflammatory drug studies with confidence.

• Transdermal Delivery of PTEN mRNA via HA-Lipid Nanoparticles

  2026-05-07

  Kim et al. present a novel hyaluronated lipid nanoparticle (HA-LNP) platform for transdermal delivery of PTEN mRNA, targeting melanoma. Their approach achieves efficient restoration of PTEN expression, induces immunogenic tumor cell death, and enhances immune activation, highlighting a promising strategy for localized mRNA-based immunotherapy.

• Applied Use of (-)-Blebbistatin in Cytoskeletal Dynamics Res

  2026-05-07

  (-)-Blebbistatin, a highly selective non-muscle myosin II inhibitor from APExBIO, delivers unparalleled control over actin-myosin interaction in live-cell and cardiac models. This guide details workflow enhancements, troubleshooting strategies, and actionable assay parameters, helping researchers unlock nuanced mechanobiology insights.

16209 records 1/1081 page Next 12345 下5页 Last page